A Case of Hemophilia A Diagnosed in a Premature Infant
![]() |
Oh, Ki-Won
(Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine)
Lee, Kyung-Yeon (Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine) Kim, Ja-Hyeong (Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine) Rhee, Kang-Won (Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine) Jeong, Jin-Young (Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine) Park, Sang-Kyu (Department of Pediatrics, Ulsan University Hospital, University of Ulsan College of Medicine) |
1 | Gelbart B, Barnes C. Severe haemophilia and extreme prematurity-a case report. Haemophilia 2009;15:352-4. DOI ScienceOn |
2 | Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed 2004;89:F475-8. DOI |
3 | Park YS. Recent advance of pharmacotherapy in hemophilia. J Korean Med Assoc 2009;52:1201-6. DOI |
4 | Kulkarni R, Lusher J. Perinatal management of newborns with haemophilia. Br J Haematol 2001;112:264-74. DOI ScienceOn |
5 | Kraft KE, Verlaak R, van Heijst AF, Novakova I, Brons PP. Management of haemophilia in three premature infants. Haemophilia 2008;14:378-80. DOI ScienceOn |
6 | Yoo KY. Hemophilia. Korean J Pediatr 2006;49:821-9. DOI ScienceOn |
7 | Baehner RL, Strauss HS. Hemophilia in the first year of life. N Engl J Med 1966;275:524-8. DOI ScienceOn |
8 | Chalmers EA. Haemophilia and the newborn. Blood Rev 2004;18:85-92. DOI ScienceOn |
9 | Kulkarni R, Lusher JM, Henry RC, Kallen DJ. Current practices regarding newborn intracranial haemorrhage and obstetrical care and mode of delivery of pregnant haemophilia carriers: a survey of obstetricians, neonatologists and haematologists in the United States, on behalf of the National Hemophilia Foundation's Medical and Scientific Advisory Council. Haemophilia 1999;5:410-5. DOI ScienceOn |
10 | Gale RF, Hird MF, Colvin BT. Management of a premature infant with moderate haemophilia A using recombinant factor VIII. Haemophilia 1998;4:850-3. DOI ScienceOn |
11 | Bidlingmaier C, Bergmann F, Kurnik K. Haemophilia A in two premature infants. Eur J Pediatr 2005;164:70-2. DOI ScienceOn |
12 | Lorenzo JI, Lopez A, Altisent C, Aznar JA. Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age. Br J Haematol 2001;113:600-3. DOI ScienceOn |
13 | van der Bom JG, Mauser-Bunschoten EP, Fischer K, van den Berg HM. Age at first treatment and immune tolerance to factor VIII in severe hemophilia. Thromb Haemost 2003;89:475-9. DOI |
14 | Gouw SC, van der Bom JG, Marijke van den Berg H. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood 2007;109:4648-54. DOI ScienceOn |
15 | Mancuso ME, Graca L, Auerswald G, Santagostino E. Haemophilia care in children-benefits of early prophylaxis for inhibitor prevention. Haemophilia 2009;15 Suppl 1:8-14. DOI |
![]() |